Literature DB >> 15914794

Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA method.

Anna Margrét Halldórsdóttir1, Joshua Stoker, Rhonda Porche-Sorbet, Charles S Eby.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914794     DOI: 10.1373/clinchem.2005.048199

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  9 in total

Review 1.  CD40/CD40L system and vascular disease.

Authors:  F Santilli; S Basili; P Ferroni; G Davì
Journal:  Intern Emerg Med       Date:  2007-11-28       Impact factor: 3.397

2.  The effect of hormone therapy and tibolone on serum CD40L and ADAM-8 in healthy post-menopausal women.

Authors:  I Lambrinoudaki; M Karaflou; G Kaparos; O Grigoriou; A Alexandrou; C Panoulis; E Logothetis; M Creatsa; G Christodoulakos; E Kouskouni
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

Review 3.  Considerations for Soluble Protein Biomarker Blood Sample Matrix Selection.

Authors:  Joel A Mathews; Yan G Ni; Connie Wang; Jon E Peterson; Chad Ray; Xuemei Zhao; Daoyu Duan; Sara Hamon; John Allinson; Martha Hokom; Greta Wegner
Journal:  AAPS J       Date:  2020-01-29       Impact factor: 4.009

4.  Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects.

Authors:  Angélique Biancotto; Xingmin Feng; Marc Langweiler; Neal S Young; J Philip McCoy
Journal:  Cytokine       Date:  2012-06-15       Impact factor: 3.861

5.  Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16.

Authors:  Benjamin A Olenchock; Stephen D Wiviott; Sabina A Murphy; Christopher P Cannon; Nader Rifai; Eugene Braunwald; David A Morrow
Journal:  J Thromb Thrombolysis       Date:  2007-10-05       Impact factor: 2.300

6.  Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.

Authors:  David A Morrow; Marc S Sabatine; Marie-Luise Brennan; James A de Lemos; Sabina A Murphy; Christian T Ruff; Nader Rifai; Christopher P Cannon; Stanley L Hazen
Journal:  Eur Heart J       Date:  2008-03-12       Impact factor: 29.983

7.  Influence of Pre-Analytical Factors on Thymus- and Activation-Regulated Chemokine Quantitation in Plasma.

Authors:  Xuemei Zhao; Liliana Delgado; Russell Weiner; Omar F Laterza
Journal:  J Circ Biomark       Date:  2015-10-27

Review 8.  Cytokines as biomarkers in rheumatoid arthritis.

Authors:  Agata Burska; Marjorie Boissinot; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-09       Impact factor: 4.711

9.  Evidence and Cost Effectiveness Requirements for Recommending New Biomarkers.

Authors:  Paul Collinson
Journal:  EJIFCC       Date:  2015-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.